The National Institutes of Health, a Technology Transfer Wellspring · BioBuzz
A lesser-known NIH facet is its long and productive history of technology transfer success.
Stay updated with breaking news from Recule Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A lesser-known NIH facet is its long and productive history of technology transfer success.
miRecule, Inc., a Gaithersburg MD-based biotech company focused on the development of RNA therapeutics, raised $5.7M in funding. The round was led by Alexandria Venture Investments, with participation from Boutique Venture Partners, Pathway Bioventures, Alumni Ventures Group, and national angel investors, Additional funding came from the Maryland Momentum Fund and the FSHD Society. The company intends to use the funds to bring its lead microRNA therapy (MC-30) to clinical development for head & neck cancer. Led by CEO Anthony Saleh, miRecule leverages the DREAmiR™ discovery platform, which...